Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neurocognitive Disorders × Dexmedetomidine × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 10 Delirium 2 Central Nervous System Diseases 2 Supratentorial Neoplasms 1 Spinal Cord Neoplasms 1 Neuroinflammatory Diseases 1 Neurofibromatoses 1 Neurocognitive Disorders 1 Neoplasms 1 Intracranial Aneurysm 1 Hypoxia 1 Hydrocephalus 1 Headache 1 Epilepsy 1 Emergence Delirium 1 Cerebrovascular Disorders 1 Abdominal Neoplasms 1

Interventions

XENP 1595 1 Sodium Chloride 1 Saline Solution 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02810899 2016-09-29

Dexmedetomidine and Intelligence Development in Pediatric Patients Undergoing Craniotomy

Peking University First Hospital

Phase 4 Completed

Brain Neoplasms, Neurocognitive Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡